Overview

Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke

Status:
Completed
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the pharmacological mechanism of Danhong injection in the treatment of acute ischemic stroke.
Phase:
Phase 4
Details
Lead Sponsor:
China Academy of Chinese Medical Sciences
Collaborator:
China Food and Drug Administration